Equity
AOCI
Boston Scientific AOCI increased by 34.8% to -$398.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1321.4%, from -$28.00M to -$398.00M. Over 5 years (FY 2020 to FY 2025), AOCI shows a downward trend with a 24.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2013
Last reportedQ1 2026May 1, 2026
How to read this metric
Fluctuations often signal changes in foreign exchange rates, interest rate environments, or pension funding status.
Detailed definition
Accumulated Other Comprehensive Income (AOCI) captures the cumulative unrealized gains and losses that are excluded from...
Peer comparison
Standard equity component for large multinational corporations with complex balance sheets.
Metric ID:
aociHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $237.00M | $238.00M | $263.00M | $222.00M | $433.00M | $532.00M | $269.00M | $178.00M | $208.00M | $231.00M | $49.00M | $132.00M | $164.00M | -$128.00M | $275.00M | -$28.00M | -$722.00M | -$689.00M | -$610.00M | -$398.00M |
| QoQ Change | — | +0.4% | +10.5% | -15.6% | +95.0% | +22.9% | -49.4% | -33.8% | +16.9% | +11.1% | -78.8% | +169.4% | +24.2% | -178.0% | +314.8% | -110.2% | <-999% | +4.6% | +11.5% | +34.8% |
| YoY Change | — | — | — | — | +82.7% | +123.5% | +2.3% | -19.8% | -52.0% | -56.6% | -81.8% | -25.8% | -21.2% | -155.4% | +461.2% | -121.2% | -540.2% | -438.3% | -321.8% | <-999% |
Range-$722.00M – $532.00M
CAGR+11.5%
Avg YoY Growth-155.4%
Median YoY Growth-54.3%
Current Streak3 quarters growth
AOCI at Other Companies
Frequently Asked Questions
- What is Boston Scientific's aoci?
- Boston Scientific (BSX) reported aoci of -$398.00M in Q1 2026.
- How has Boston Scientific's aoci changed year-over-year?
- Boston Scientific's aoci decreased by 1321.4% year-over-year, from -$28.00M to -$398.00M.
- What is the long-term trend for Boston Scientific's aoci?
- Over 5 years (2020 to 2025), Boston Scientific's aoci has grown at a 24.1% compound annual growth rate (CAGR), from $207.00M to -$610.00M.
- What does aoci mean?
- The cumulative total of unrealized gains and losses not yet reflected in net income.